ArticlePain and therapy2024

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain.

Xiaohui Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.